Showing results (701-710 of 805) with videos related to
Sort By:
Pageof 81
The American Journal of Cardiology|October 1, 2016
Effect of Body Mass Index on Left Ventricular Mass in Career Male FirefightersMaria Korre, Luiz Guilherme G Porto, Andrea Farioli, et al.BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.Thrombosis Research|October 6, 2023
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort studyYan Xu, Faizan Khan, Michael J Kovacs, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertensionV R Holla, F Adas, J D Imig, et al.Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.Alcohol (Fayetteville, N.Y.)|November 2, 2015
Summary of the 2014 Alcohol and Immunology Research Interest Group (AIRIG) meetingAdam M Hammer, Niya L Morris, Abigail R Cannon, et al.Journal of Thrombosis and Haemostasis : JTH|February 21, 2009
Validation of a diagnostic approach to exclude recurrent venous thromboembolismG Le Gal, M J Kovacs, M Carrier, et al.Journal of Thrombosis and Haemostasis : JTH|June 22, 2010
Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolismM J Kovacs, S R Kahn, P S Wells, et al.Alcohol (Fayetteville, N.Y.)|April 15, 2018
Summary of the 2017 Alcohol and Immunology Research Interest Group (AIRIG) meetingHolly J Hulsebus, Brenda J Curtis, Patricia E Molina, et al.Cardiovascular Toxicology|December 10, 2014
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose StudyRichard J Kovacs, Giuliana Maldonado, Analia Azaro, et al.Pageof 81